Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 26:5:54.
doi: 10.3389/fchem.2017.00054. eCollection 2017.

Analysis of Urine Composition in Type II Diabetic Mice after Intervention Therapy Using Holothurian Polypeptides

Affiliations

Analysis of Urine Composition in Type II Diabetic Mice after Intervention Therapy Using Holothurian Polypeptides

Yanyan Li et al. Front Chem. .

Abstract

Hydrolysates and peptide fractions (PF) obtained from sea cucumber with commercial enzyme were studied on the hyperglycemic and renal protective effects on db/db rats using urine metabolomics. Compared with the control group the polypeptides from the two species could significantly reduce the urine glucose and urea. We also tried to address the compositions of highly expressed urinary proteins using a proteomics approach. They were serum albumins, AMBP proteins, negative trypsin, elastase, and urinary protein, GAPDH, a receptor of urokinase-type plasminogen activator (uPAR), and Ig kappa chain C region. We used the electronic nose to quickly detect changes in the volatile substances in mice urine after holothurian polypeptides (HPP) fed, and the results show it can identify the difference between treatment groups with the control group without overlapping. The protein express mechanism of HPP treating diabetes was discussed, and we suggested these two peptides with the hypoglycemic and renal protective activity might be utilized as nutraceuticals.

Keywords: express mechanism; function; holothurian polypeptides; type II diabetes; urine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Two-dimensional electrophoregram. C, Control group; M, model group; Me, positive drug group; A, A. molpadioides's polypeptide group; S, A. japonicus's polypeptide group.
Figure 2
Figure 2
Odor analysis of urine samples of db/db mice using electronic nose. C, Control group; M, model group; Me, positive drug group; A, A. molpadioides's polypeptide group; S, A. japonicus's polypeptide group. (Top) PCA; (Bottom) LDA.
Figure 3
Figure 3
Volatile compounds in the urine of db/db mice. C, Control group; M, model group; Me, positive drug group; A, A. molpadioides's polypeptide group; S, A. japonicus's polypeptide group.
Figure 4
Figure 4
Contents of metabolites in the urine of db/db mice. C, Control group; M, model group; Me, positive drug group; A, A. molpadioides's polypeptide group; S, A. japonicus's polypeptide group. I, Analysis of intersection of metabolites in each group; II, Alcohols; III, Amines. Additives; IV Organic acids; V, Sugar; VI, Amino acids; VII, Amino acid derivatives; VIII, Ammoniums; IX, Nucleic acids; X, Vitamins; XI, Additives; XII, Ketones.

Similar articles

Cited by

References

    1. Adrian T., Barnes A., Bloom S. (1979). Hypotrypsinaemia in diabetes mellitus. Clin. Chim. Acta 97, 213–216. 10.1016/0009-8981(79)90418-2 - DOI - PubMed
    1. Beckonert O., Keun H. C., Ebbels T. M., Bundy J., Holmes E., Lindon J. C., et al. . (2007). Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2, 2692–2703. 10.1038/nprot.2007.376 - DOI - PubMed
    1. Bingol K., BrüSchweiler R. (2015). NMR/MS Translator for the enhanced simultaneous analysis of metabolomics mixtures by NMR spectroscopy and mass spectrometry: application to human urine. J. Proteome Res. 14, 2642–2648. 10.1021/acs.jproteome.5b00184 - DOI - PMC - PubMed
    1. Bordbar S., Anwar F., Saari N. (2011). High-value components and bioactives from sea cucumbers for functional foods—a review. Mar. Drugs 9, 1761–1805. 10.3390/md9101761 - DOI - PMC - PubMed
    1. Brownlee M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813–820. 10.1038/414813a - DOI - PubMed